Evidence Review
Noise Stress Crossover RCT (Deijen & Orlebeke, 1994)
The earliest well-designed human trial was a crossover study in 16 healthy young adults [1]. On two separate test days, participants received either tyrosine (100 mg/kg) or placebo and then completed a battery of cognitive tasks while exposed to 90 dB noise as a stressor. Tyrosine improved performance on two tasks that were characterized as particularly sensitive to stress. The drug also reduced diastolic blood pressure 15 minutes post-ingestion, though systolic pressure and heart rate were unaffected. Mood measures showed no significant change. The crossover design — each participant serving as their own control — strengthened the statistical power despite the small sample size.
Military Combat Training (Deijen et al., 1999)
Deijen's group followed up with a more ecologically valid trial: 21 Dutch military cadets divided into a tyrosine group (n = 10) receiving a protein drink containing 2 g of tyrosine per serving, five times daily over a six-day combat course, and a control group (n = 11) receiving an isocaloric carbohydrate drink [2]. Performance was assessed before and on the sixth day of the course, which involved sustained physical and psychological stress.
The tyrosine group performed significantly better on both a memory task and a tracking task. Systolic blood pressure was lower in the tyrosine group. Urinary MHPG (a norepinephrine metabolite) and mood scores showed no significant difference between groups. The authors interpreted the blood pressure and cognitive findings as consistent with norepinephrine modulation under genuine operational stress — a setting where catecholamine depletion is expected and where the supplement would have maximal mechanistic impact.
Rapid Evidence Assessment of 14 Trials (Attipoe et al., 2015)
Attipoe and colleagues conducted a systematic review for the U.S. military using the Samueli Institute's Rapid Evidence Assessment of the Literature (REAL) methodology [3]. Databases including PubMed/MEDLINE, CINAHL, Embase, and PsycInfo were searched up to October 2012. Fourteen studies met inclusion criteria: 10 randomized controlled trials and 4 controlled clinical trials.
All 10 RCTs that tested tyrosine against cognitive stress produced a positive result. No recommendation could be made for tyrosine's effect on physical performance, as the evidence there was inconsistent. For cognitive stress specifically, the authors made a weak-positive recommendation — weak because sample sizes were modest and the research base was not yet large enough for a strong recommendation, but positive because the direction of effect was unanimous. The review used GRADE criteria for quality assessment, giving the findings a structured analytical foundation.
Clinical Review with Mechanistic Analysis (Jongkees et al., 2015)
Jongkees and colleagues reviewed tyrosine research across both clinical populations (phenylketonuria patients, who cannot convert phenylalanine to tyrosine efficiently) and healthy people under stress and cognitive demands [4]. Published in the Journal of Psychiatric Research, the review clarified the mechanistic picture: tyrosine's benefits in healthy people are closely tied to situations where catecholamine turnover is elevated. The authors noted that depletion studies — where tyrosine and phenylalanine are experimentally removed from the diet — consistently impair working memory and spatial planning, which provides strong causal evidence that the effect runs through catecholamine synthesis. They emphasized that tyrosine supplementation in non-stressed, well-rested individuals is unlikely to provide cognitive benefit, which is consistent with the mechanistic model.
DRD2 Genotype RCT (Colzato et al., 2016)
A double-blind, randomized, placebo-controlled trial by Colzato and colleagues examined whether dopamine receptor genetics explain the variable individual responses to tyrosine [5]. Participants were genotyped for the C957T polymorphism in the DRD2 gene (rs6277), which influences striatal dopamine receptor density. Those carrying the T/T genotype — associated with lower striatal dopamine levels — showed significantly larger benefits from tyrosine on both working memory (N-back task) and inhibitory control (stop-signal task) than C/C homozygotes.
This finding has important practical implications: it suggests that tyrosine supplementation is not universally beneficial, but is most valuable for individuals whose baseline dopamine function is on the lower end of the normal range. It also helps explain why some trials report robust effects while others show minimal response — population heterogeneity in dopamine genetics may drive much of the variance.
Strength of Evidence
The evidence base for L-tyrosine's cognitive effects under stress is moderately strong by supplement standards: uniform direction of effect across RCTs, a biologically plausible and well-characterized mechanism, and a clarifying genetic framework that explains individual variation. The primary limitations are the generally small sample sizes in individual trials, the reliance on acute dosing protocols, and the near-exclusive focus on military or student populations. Long-term supplementation trials in general populations are lacking. The evidence justifies situational use in genuinely demanding circumstances, with realistic expectations about the scope and magnitude of effect.